-
Location
-
C/O Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington, VA
-
Summary
-
The estimated value of insider holdings of Sands Capital Life Sciences Pulse Fund II, L.P. is at least $24.4M dollars as of July 15, 2025. Sands Capital Life Sciences Pulse Fund II, L.P. is the 10%+ Owner of Inhibikase Therapeutics, Inc. and owns shares of Inhibikase Therapeutics, Inc. (IKT) stock worth about $24.4M.
-
Signature
-
Sands Capital Life Sciences Pulse Fund II, L.P., By: Sands Capital Life Sciences Pulse Fund II-GP, L.P., its General Partner, By: Sands Capital Life Sciences Pulse Fund II-GP, LLC, its General Partner, By: /s/ Jonathan Goodman, General Counsel